Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CSPC Pharmaceutical Group ( (HK:1093) ) has shared an announcement.
CSPC Pharmaceutical Group Limited has announced the composition of its board of directors, highlighting the roles and functions of each member. This announcement provides clarity on the leadership structure and governance, which could impact the company’s strategic direction and reassure stakeholders about its management stability.
The most recent analyst rating on (HK:1093) stock is a Buy with a HK$11.05 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a Hong Kong-incorporated company operating in the pharmaceutical industry. It focuses on the development, manufacturing, and marketing of pharmaceutical products.
Average Trading Volume: 147,790,246
Technical Sentiment Signal: Buy
Current Market Cap: HK$87.08B
For a thorough assessment of 1093 stock, go to TipRanks’ Stock Analysis page.